Michael J. Wagner

3.3k citations

34 papers · 2.1k indexed · 1 hit paper · h-index 18

Genetics top 2%
Molecular Biology top 10%
Pharmacology top 1%
Endocrinology, Diabetes and Metabolism top 5%
Epidemiology

Co-authors: Margaret G. Ehm Dmitri V. Zaykin Peter H. Westfall Alison A. Motsinger‐Reif William C. Summers Wilma P. Summers Zhaoling Meng Chun‐Fang Xu
Topics: Genetic Associations and Epidemiology (16 papers)Genomic variations and chromosomal abnormalities (7 papers)Genomics and Rare Diseases (6 papers)
Cited by: Genetics Pharmacology Endocrinology, Diabetes and Metabolism
Journals: Proceedings of the National Academy of Sciences Blood Diabetes Care
Partner nations: United States Canada United Kingdom

In The Last Decade

Michael J. Wagner

34 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Testing Association of Statistically Inferred Haplotypes with Discrete and Continuous Traits in Samples of Unrelated Individuals

2002 547 citations Dmitri V. Zaykin, Peter H. Westfall et al. Human Heredity profile →

Peers

Countries citing papers authored by Michael J. Wagner

Since Specialization

Citations

This map shows the geographic impact of Michael J. Wagner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Wagner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Wagner more than expected).

Fields of papers citing papers by Michael J. Wagner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael J. Wagner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Wagner. The network helps show where Michael J. Wagner may publish in the future.

Co-authorship network of co-authors of Michael J. Wagner

This figure shows the co-authorship network connecting the top 25 collaborators of Michael J. Wagner. A scholar is included among the top collaborators of Michael J. Wagner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael J. Wagner. Michael J. Wagner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Genetic Locus on Chromosome 2q24 Predicting Peripheral Neuropathy Risk in Type 2 Diabetes: Results From the ACCORD and BARI 2D Studies 2019 ·Diabetes ·Yaling Tang,Petra Lenzini,Rodica Pop‐Busui,(unknown),(unknown),Bruce A. Perkins,Brian C. Callaghan,Michael J. Wagner,Alison A. Motsinger‐Reif,John B. Buse,Theodore J. Price,Josyf C. Mychaleckyj,Sharon Cresci,Hetal Shah,Alessandro Doria	26
2	Identifying individual risk rare variants using protein structure guided local tests (POINT) 2019 ·PLoS Computational Biology ·Rachel Marceau West,Wenbin Lu,Daniel M. Rotroff,Mélaine A. Kuenemann,Sheng‐Mao Chang,Michael C. Wu,Michael J. Wagner,John B. Buse,Alison A. Motsinger‐Reif,Denis Fourches,Jung‐Ying Tzeng	8
3	Pharmacogenetic Analysis of the Model‐Based Pharmacokinetics of Five Anti‐HIV Drugs: How Does This Influence the Effect of Aging? 2017 ·Clinical and Translational Science ·Jingxian Chen,Farida S. Akhtari,Michael J. Wagner,Oscar Suzuki,Tim Wiltshire,Alison A. Motsinger‐Reif,Julie B. Dumond	7
4	Common and rare genetic markers of lipid variation in subjects with type 2 diabetes from the ACCORD clinical trial 2017 ·PeerJ ·Skylar W. Marvel,Daniel M. Rotroff,Michael J. Wagner,John B. Buse,Tammy M. Havener,Howard L. McLeod,Alison A. Motsinger‐Reif,(unknown)	9
5	Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes 2017 ·Clinical Pharmacology & Therapeutics ·Daniel M. Rotroff,(unknown),Skylar W. Marvel,John Jack,Tammy M. Havener,Aurora Pujol,Agatha Schlüter,Gregory A. Graf,Henry N. Ginsberg,Hetal Shah,He Gao,Mario Luca Morieri,Alessandro Doria,(unknown),Howard L. McLeod,John B. Buse,Michael J. Wagner,Alison A. Motsinger‐Reif,(unknown)	25
6	Incorporating Concomitant Medications into Genome-Wide Analyses for the Study of Complex Disease and Drug Response 2016 ·Frontiers in Genetics ·(unknown),Daniel M. Rotroff,Skylar W. Marvel,John B. Buse,Tammy M. Havener,Alyson G. Wilson,Michael J. Wagner,Alison A. Motsinger‐Reif	2
7	A genome-wide study of lipid response to fenofibrate in Caucasians 2016 ·Pharmacogenetics and Genomics ·Marguerite R. Irvin,Daniel M. Rotroff,Stella Aslibekyan,Degui Zhi,Bertha Hidalgo,Alison A. Motsinger‐Reif,Skylar W. Marvel,Vinodh Srinivasasainagendra,Steven A. Claas,John B. Buse,Robert J. Straka,José M. Ordovás,Ingrid B. Borecki,Xiuqing Guo,(unknown),Jerome I. Rotter,Michael J. Wagner,Donna K. Arnett	13
8	A Phenotype–Genotype Approach to Predicting CYP450 and P-Glycoprotein Drug Interactions With the Mixed Inhibitor/Inducer Tipranavir/Ritonavir 2010 ·Clinical Pharmacology & Therapeutics ·Julie B. Dumond,Manoli Vourvahis,Nardin Rezk,Kristine B. Patterson,H.-C. Tien,Nicole White,(unknown),(unknown),(unknown),Michael J. Wagner,Ninh M. La‐Beck,(unknown),John P. Sabo,(unknown),Thomas R. MacGregor,Angela D. M. Kashuba	48
9	Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groups 2010 ·Blood ·Nita A. Limdi,Mia Wadelius,Larisa H. Cavallari,Niclas Eriksson,Dana C. Crawford,Ming Ta Michael Lee,Chien‐Hsiun Chen,Alison A. Motsinger‐Reif,Hersh Sagreiya,Nianjun Liu,Alan H.B. Wu,Brian F. Gage,Andrea Jorgensen,Munir Pirmohamed,Jae‐Gook Shin,Guilherme Suarez‐Kurtz,Stephen E. Kimmel,Julie A. Johnson,Teri E. Klein,Michael J. Wagner	279
10	Genomewide association for schizophrenia in the CATIE study: results of stage 1 2008 ·Molecular Psychiatry ·Patrick F. Sullivan,D. Y. Lin,(unknown),Edwin van den Oord,Diana O. Perkins,T. Scott Stroup,Michael J. Wagner,Seonjoo Lee,Fred A. Wright,Fei Zou,(unknown),AnnCatherine M. Downing,Jeffrey A. Lieberman,Sandra Close	265
11	Case‐control single‐marker and haplotypic association analysis of pedigree data 2004 ·Genetic Epidemiology ·Sharon R. Browning,(unknown),Linda P. Briley,Gyan Chandra,(unknown),Margaret G. Ehm,(unknown),(unknown),Andrew J. Karter,David P. Yarnall,Michael J. Wagner	41
12	Linkage Analysis Using Single Nucleotide Polymorphisms 2004 ·Human Heredity ·Brian L. Browning,(unknown),(unknown),(unknown),E Clare Harris,Anita J. Nelsen,David P. Yarnall,Margaret G. Ehm,Michael J. Wagner	8
13	Selection of Genetic Markers for Association Analyses, Using Linkage Disequilibrium and Haplotypes 2003 ·The American Journal of Human Genetics ·Zhaoling Meng,Dmitri V. Zaykin,Chun‐Fang Xu,Michael J. Wagner,Margaret G. Ehm	114
14	Testing Association of Statistically Inferred Haplotypes with Discrete and Continuous Traits in Samples of Unrelated Individualsbreakdown → 2002 ·Human Heredity ·Dmitri V. Zaykin,Peter H. Westfall,(unknown),(unknown),Michael J. Wagner,Margaret G. Ehm	547
15	Genomewide Search for Type 2 Diabetes Susceptibility Genes in Four American Populations 2000 ·The American Journal of Human Genetics ·Margaret G. Ehm,Maha Karnoub,H. Sakul,William Gottschalk,(unknown),James L. Weber,D. A. Vaske,(unknown),Linda P. Briley,(unknown),Patrick McMillen,Quan Nguyen,(unknown),Eric Lai,Geoff Joslyn,Nancy S. Shepherd,Callum J. Bell,Michael J. Wagner,Daniel K. Burns	155
16	A Test Statistic to Detect Errors in Sib-Pair Relationships 1998 ·The American Journal of Human Genetics ·Margaret G. Ehm,Michael J. Wagner	47
17	Assignment of fragile site 8E (FRA8E) to human chromosome band 8q24.11 adjacent to the hereditary multiple exostoses 1 gene and two overlapping Langer-Giedion syndrome deletion endpoints 1997 ·Cytogenetic and Genome Research ·Anthony F. Hill,Yosuke Harada,Eiichi Takahashi,Jian Hou,Michael J. Wagner,Dan E. Wells	2
18	An Integrated Physical Map Covering 25 cM of Human Chromosome 8 1996 ·Genomics ·Wen‐Shan Chen,Jiakai Hou,Michael J. Wagner,Dan E. Wells	10
19	Construction of 110 Cosmid Markers and a 4.5-Mb YAC Contig on Human Chromosome 8p12-q11 1995 ·Genomics ·Akihiro Kurimasa,Noriyuki Suzuki,Satoshi Kumano,Hua Li,Dan E. Wells,Michael J. Wagner,Fanqing Chen,David J. Chen,Mitsuo Oshimura	4
20	Alignment of physical and genetic maps of human 8q23-qter using somatic cell hybrid mapping panel 1994 ·Somatic Cell and Molecular Genetics ·Julia Parrish,Yang Wang,Michael J. Wagner,Dan E. Wells	6

About Michael J. Wagner

Michael J. Wagner is a scholar working on Genetics, Pharmacology and Developmental Biology, having authored 34 papers that have together received 2.1k indexed citations. Recurring topics across this work include Genetic Associations and Epidemiology (16 papers), Genomic variations and chromosomal abnormalities (7 papers) and Genomics and Rare Diseases (6 papers). The work is most often cited by research in Genetics (1.1k citations), Pharmacology (288 citations) and Endocrinology, Diabetes and Metabolism (284 citations). Michael J. Wagner has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Margaret G. Ehm, Dmitri V. Zaykin, Peter H. Westfall, Alison A. Motsinger‐Reif, William C. Summers, Wilma P. Summers, Zhaoling Meng, Chun‐Fang Xu, Callum J. Bell and Edwin van den Oord. Their work appears in journals such as Proceedings of the National Academy of Sciences, Blood and Diabetes Care.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact